REACH-ASD Trial: A randomised controlled trial of a new workshop programme offering information, empowerment and emotional support to parents of children recently diagnosed with Autism Spectrum Disorder

Not Applicable

Completed

• Conditions: Mental health and well-being of parents/caregivers of children recently diagnosed with Autism Spectrum Disorder (ASD); Mental and Behavioural Disorders

• Registration Number: ISRCTN45412843
• Lead Sponsor: Manchester University NHS Foundation Trust

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35869533/ (added 25/07/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-11
• Study Completion: 2023-04-30
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 379

Inclusion Criteria

Current inclusion criteria as of 13/10/2020:
1. At consent, child aged between 2 years 0 months and 15 years 11 months. This is the age-range typically seen by ASD diagnostic teams.
2. At referral, child with a diagnosis of ASD from an NHS professional within the last 12 months.
3. One index” adult (child’s parent/primary caregiver; must be aged 18 years or over) per child, nominated by family on intention to participate” basis
4. Child with ASD is a patient of one of the trial collaborating centres

Previous inclusion criteria:
1. At consent, child aged between 2 years 0 months and 15 years 11 months with a diagnosis of ASD from an NHS professional within the last 12 months.
2. One index” adult (child’s parent/primary caregiver; must be aged 18 years or over) per child, nominated by family on intention to participate” basis
3. Child with ASD is a patient of one of the trial collaborating centres

Exclusion Criteria

1. Adult with insufficient English language to preclude participation
2. Adult with significant learning disability or significant hearing/visual impairment to preclude participation
3. Adult with current severe psychiatric condition to preclude participation
4. Significant current safeguarding concerns within family, identified by referring clinician

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Parental mental health assessed using General Health Questionnaire- 30 at 1-year follow-up